Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Alymsys“
Suchtreffer
Begriffe & Kennungen
Alymsys
Eintrag öffnenAlymsys · 4.1 Therapeutic indications · 1
Eintrag öffnenAlymsys · 4.3 Contraindications · 1
Eintrag öffnenAlymsys · 4.3 · • Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. • Hypersensitivi
Eintrag öffnenAlymsys · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenAlymsys · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenAlymsys · 4.5 · 9 interferon alfa-2a, erlotinib or chemotherapies (IFL, 5-FU/LV, carboplatin/paclitaxel, capecitabine, doxorub
Eintrag öffnenAlymsys · 4.5 · Combination of bevacizumab and sunitinib malate
Eintrag öffnenAlymsys · 4.5 · Combination with platinum- or taxane-based therapies (see sections 4.4 and 4.8)
Eintrag öffnenAlymsys · 4.5 · EGFR monoclonal antibodies in combination with bevacizumab chemotherapy regimens
Eintrag öffnenAlymsys · 4.5 · Effect of antineoplastic agents on bevacizumab pharmacokinetics
Eintrag öffnenAlymsys · 4.5 · Effect of bevacizumab on the pharmacokinetics of other antineoplastic agents
Eintrag öffnenAlymsys · 4.5 · In two clinical trials of metastatic renal cell carcinoma, microangiopathic haemolytic anaemia (MAHA) was repo
Eintrag öffnenAlymsys · 4.5 · Increased rates of severe neutropenia, febrile neutropenia, or infection with or without severe neutropenia (i
Eintrag öffnenAlymsys · 4.5 · MAHA is a haemolytic disorder which can present with red cell fragmentation, anaemia, and thrombocytopenia. In
Eintrag öffnenAlymsys · 4.5 · No clinically relevant interaction of bevacizumab was observed on the pharmacokinetics of co-administered inte
Eintrag öffnenAlymsys · 4.5 · No clinically relevant interaction of co-administered chemotherapy on bevacizumab pharmacokinetics was observe
Eintrag öffnenAlymsys · 4.5 · No interaction studies have been performed. EGFR monoclonal antibodies should not be administered for the trea
Eintrag öffnenAlymsys · 4.5 · Radiotherapy
Eintrag öffnenAlymsys · 4.5 · The safety and efficacy of concomitant administration of radiotherapy and bevacizumab has not been established
Eintrag öffnen